代谢相关性脂肪性肝病无创诊断方法研究进展  

Progress of noninvasive diagnosis of metabolic associated fatty liver disease

作　　者：崔会鹏 田昊宇 关琳[1] 李异玲[1] CUI Huipeng;TIAN Haoyu;GUAN Lin;LI Yiling(Department of Gastroenterology,the First Affiliated Hospital of China Medical University,Shenyang 110001;China Medical University,China)

机构地区：[1]中国医科大学附属第一医院消化内科,辽宁沈阳110001 [2]中国医科大学

出　　处：《胃肠病学和肝病学杂志》2022年第1期99-103,共5页Chinese Journal of Gastroenterology and Hepatology

摘　　要：据估计,全球约有25%的成年人患有代谢相关性脂肪性肝病(metabolic associated fatty liver disease,MAFLD),且发病率逐年上升。肝脏活检仍是诊断MAFLD的金标准。近年来,无创诊断方法发展比较迅速。本文针对MAFLD的无创诊断研究进展进行了较为系统的综述。It is estimated that about 25%of the world’s adults suffer from metabolic associated fatty liver disease(MAFLD)and the incidence is increasing year by year.Liver biopsy is still the gold standard for the diagnosis of MAFLD.In recent years,noninvasive diagnostic methods have developed rapidly.We reviewed the progress of noninvasive diagnosis of MAFLD.

关 键 词：代谢相关性脂肪性肝病 超声 瞬时弹性成像 质子密度脂肪分数 

分 类 号：R575[医药卫生—消化系统]